This inventor holds 2 USPTO granted patents. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 1998-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-1999
Title: Udy Olshevsky: Innovator in Immunogenic Peptides
Introduction
Udy Olshevsky is a notable inventor based in Remath-Oan, IL. He has made significant contributions to the field of immunology, particularly in the development of immunogenic peptides and antibodies. His work has implications for treatment and prophylaxis related to CD4 receptors.
Latest Patents
Udy Olshevsky holds 2 patents that focus on immunogenic peptides and antibodies related to CD4. His latest patents disclose immunogenic peptides containing amino acid residues that define a binding site to a CD4 receptor. Additionally, antibodies to these peptides are also described. The patents include methods for reducing the ability of a gp120 env protein to bind to CD4, as well as methods of treatment and prophylaxis using these antibodies and peptides.
Career Highlights
Udy Olshevsky is associated with the Dana-Farber Cancer Institute Inc., where he continues to advance research in immunology. His innovative work has positioned him as a key figure in the development of therapeutic strategies targeting CD4 receptors.
Collaborations
Udy has collaborated with prominent scientists in the field, including Joseph G Sodroski and William A Haseltine. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Udy Olshevsky's contributions to immunogenic peptides and antibodies have the potential to significantly influence treatment options for various diseases. His work exemplifies the importance of innovation in the field of immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile